Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-ranging Clinical Trial to Study the Efficacy and Safety of DR-2031 for the Treatment of Hot Flashes Following Surgical or Medical Castration of Prostate Cancer Patients

NCT00196339 is registered in ClinicalTrials.gov with Duramed Research as lead sponsor.

NCT NCT00196339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00196339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-ranging Clinical Trial to Study the Efficacy and Safety of DR-2031 for the Treatment of Hot Flashes Following Surgical or Medical Castration of Prostate Cancer Patients
Lead sponsor
Duramed Research
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2005
Completion date
January 31, 2008
Enrollment
315 (actual)
Sites
118

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer